Cite
HARVARD Citation
Martin, D. et al. (n.d.). SAT0235 BIIB059, a monoclonal antibody targeting BCDA2 shows safety, tolerability, pharmacokinetics, pharmacodynamics in healthy volunteer subjects. Annals of the rheumatic diseases. p. 862. [Online].